Neuronano AB

Today is World Parkinson’s Day Parkinson’s disease is one of the most common neurological diseases in the world. Every year life changes drastically for thousands as they find themselves diagnosed with the disease. At Neuronano, our aim is to improve the quality of life for patients suffering from Parkinson’s with the help of groundbreaking nanotechnology. Find out more about what we are doing, to improve the Deep Brain Stimulation technology with greater precision than ever before achieved, by visiting www.neuronano.se

On Sunday the 13th January an article was published in Svenska Dagbladet, with the title The Swede who makes the ideas of Elon Musk come true. In the article Jens Schouenborg gives his thoughts on Elon Musk and the work of Neuralink and how Neuronano's research differentiates in both purpose and approach. (In Swedish).

Wednesday the third of February an article with the title Modern teknik öppnar vägen in till hjärnan (translated: New technology enters the brain) was published in the Swedish magazine NyTeknik. In the article Jens Schouenborg gives his views on Neuronano AB’s and Neuronano Research Center’s groundbreaking research when it comes to treatments for pain and neurodegenerative diseases such as Parkinson's disease. (In Swedish). https://neuronano.se/neuronano-interview-nyteknik

Our principal inventor Jens Schouenborg was featured on SVT Rapport, a swedish news channel, where he explains the DBS technology being developed here at Neuronano. https://neuronano.se/jens-schouenborg-rapport